Download Publications for Preeyaporn Srasuebkul Publications for Preeyaporn

Publications for Preeyaporn Srasuebkul
Publications for Preeyaporn
Srasuebkul
2016
Langton, J., Reeve, R., Srasuebkul, P., Haas, M.,
Viney, R., Currow, D., Pearson, S. (2016).
Health service use and costs in the last 6 months
of life in elderly decedents with a history of
cancer: A comprehensive analysis from a health
payer perspective. British Journal of Cancer,
114(11), 1293-1302. <a
href="http://dx.doi.org/10.1038/bjc.2016.75">[M
ore Information]</a>
Parkinson, B., Viney, R., Haas, M., Goodall, S.,
Srasuebkul, P., Pearson, S. (2016). Real-World
Evidence: A Comparison of the Australian
Herceptin Program and Clinical Trials of
Trastuzumab for HER2-Positive Metastatic
Breast Cancer. PharmacoEconomics, 34(10),
1039-1050. <a
href="http://dx.doi.org/10.1007/s40273-016-041
1-2">[More Information]</a>
2015
Pearson, S., Abrahamowicz, M., Srasuebkul, P.,
Buckley, N. (2015). Antidepressant therapy in
cancer patients: initiation and factors associated
with treatment. Pharmacoepidemiology and
Drug Safety, 24(6), 600-609. <a
href="http://dx.doi.org/10.1002/pds.3753">[Mor
e Information]</a>
Pearce, A., Haas, M., Viney, R., Haywood, P.,
Pearson, S., Van Gool, K., Srasuebkul, P., Ward,
R. (2015). Can administrative data be used to
measure chemotherapy side effects? Expert
Review of Pharmacoeconomics and Outcomes
Research, 15(2), 215-222. <a
href="http://dx.doi.org/10.1586/14737167.2015.
990888">[More Information]</a>
Langton, J., Srasuebkul, P., Reeve, R.,
Parkinson, B., Gu, Y., Buckley, N., Haas, M.,
Viney, R., Pearson, S. (2015). Resource use,
costs and quality of end-of-life care: observations
in a cohort of elderly Australian cancer
decedents. Implementation Science, 10(1), 1-14.
<a
href="http://dx.doi.org/10.1186/s13012-014-014
8-2">[More Information]</a>
Lu, C., Srasuebkul, P., Drew, A., Chen, K.,
Ward, R., Pearson, S. (2013). Trastuzumab
therapy in Australia: Which patients with HER2+
metastatic breast cancer are assessed for cardiac
function? The Breast, 22(4), 482-487. <a
href="http://dx.doi.org/10.1016/j.breast.2013.04.
011">[More Information]</a>
2012
Lu, C., Srasuebkul, P., Drew, A., Ward, R.,
Pearson, S. (2012). Positive spillover effects of
prescribing requirements: Increased cardiac
testing in patients treated with trastuzumab for
HER2+ metastatic breast cancer. Internal
Medicine Journal, 42(11), 1229-1235. <a
href="http://dx.doi.org/10.1111/j.1445-5994.201
1.02604.x">[More Information]</a>
2010
Hansudewechakul, R., Sirisanthana, V., Kurniati,
N., Puthanakit, T., Lumbiganon, P., Saphonn, V.,
Yusoff, N., Kumarasamy, N., Fong, S.,
Nallusamy, R., et al (2010). Antiretroviral
therapy outcomes of HIV-infected children in the
TREAT Asia pediatric HIV observational
database. JAIDS-Journal of Acquired Immune
Deficiency Syndromes, 55(4), 503-509. <a
href="http://dx.doi.org/10.1097/QAI.0b013e318
1f5379a">[More Information]</a>
Puls, R., Srasuebkul, P., Petoumenos, K.,
Boesecke, C., Duncombe, C., Belloso, W.,
Molina, J., Li, L., Avihingsanon, A., Gazzard,
B., et al (2010). Efavirenz versus boosted
atazanavir or zidovudine and abacavir in
antiretroviral treatment-naive, HIV-infected
subjects: week 48 data from the Altair study.
Clinical Infectious Diseases, 51(7), 855-864. <a
href="http://dx.doi.org/10.1086/656363">[More
Information]</a>
Srasuebkul, P., Pearson, S., Harris, C., Ward, R.,
Dobbins, T. (2010). The impact of oestrogen
receptor (ER) status on overall survival of
metastatic breast cancer patients receiving
trastuzumab in Australia. 16th Annual Japanese
Society for Pharmacoepidemiology Meeting and
the 5th Annual Asian Conference on
Pharmacoepidemiology, Japan: ACPE.
2009
Srasuebkul, P., Dobbins, T., Pearson, S. (2014).
Validation of a proxy for estrogen receptor status
in breast cancer patients using dispensing data.
Asia-Pacific Journal of Clinical Oncology,
10(2), e63-e68. <a
href="http://dx.doi.org/10.1111/ajco.12015">[M
ore Information]</a>
Pujari, S., Srasuebkul, P., Sungkanuparph, S.,
Lim, P., Kumarasamy, N., Chuah, J., Kumar, R.,
Chen, Y., Oka, S., Choi, J., et al (2009). Patient
characteristics and treatment outcome associated
with Protease Inhibitor (PI) use in the
Asia-Pacific region. Journal of Antivirals and
Antiretrovirals, 1(1), 28-35. <a
href="http://dx.doi.org/10.4172/jaa.1000004">[
More Information]</a>
2013
Srasuebkul, P., Sungkanuparph, S., Lim, P., Law,
2014
Publications for Preeyaporn Srasuebkul
M. (2009). Reply to DiNubile. Clinical
Infectious Diseases, 49(5), 811-812. <a
href="http://dx.doi.org/10.1086/605290">[More
Information]</a>
content in patients switched from failed
nucleoside analogue therapy to retonavir-boosted
indinavir and efavirenz. The Journal of
Infectious Diseases, 194(5), 642-650.
Srasuebkul, P., Lim, P., Lee, M., Kumarasamy,
N., Zhou, J., Sirisanthana, T., Li, P.,
Kamarulzaman, A., Oka, S., Phanuphak, P., et al
(2009). Short Term Clinical Disease Progression
in HIV Infected Patients Receiving Combination
Antiretroviral Therapy: Results from the TREAT
Asia HIV Observational Database. Clinical
Infectious Diseases, 48(7), 940-950. <a
href="http://dx.doi.org/10.1086/597354">[More
Information]</a>
Nuesch, R., Srasuebkul, P., Ananworanich, J.,
Ruxrungtham, K., Phanuphak, P., Duncombe, C.
(2006). Monitoring the toxicity of antiretroviral
therapy in resource limited settings: a
prospective clinical trial cohort in Thailand.
Journal of Antimicrobial Chemotherapy, 58(3),
637-644. <a
href="http://dx.doi.org/10.1093/jac/dkl313">[Mo
re Information]</a>
2008
Nuesch, R., Ananworanich, J., Srasuebkul, P.,
Chetchotisakd, P., Prasithsirikul, W.,
Klinbuayam, W., Mahanontharit, A., Juppimai,
T., Ruxrungtham, K., Hirschel, B. (2008).
Interruptions of tenofovir/emtricitabine based
ART in patients with HIV/HBV co-infection.
AIDS, 22(1), 152-154. <a
href="http://dx.doi.org/10.1097/QAD.0b013e328
2f303bf">[More Information]</a>
2007
Srasuebkul, P., Calmy, A., Zhou, J.,
Kumarasamy, N., Law, M., Lim, P. (2007).
Impact of drug classes and threatment
availability on the rate of antiretroviral treatment
change in the TREAT Asia HIV Observational
Databade (TAHOD). AIDS Research and
Therapy, 4(18), 1-10. <a
href="http://dx.doi.org/10.1186/1742-6405-4-18"
>[More Information]</a>
Srasuebkul, P., Ungsedhapand, C.,
Ruxrungtham, K., Boyd, M., Phanuphak, P.,
Cooper, D., Law, M. (2007). Predictive factors
for immunological and virological endpoints in
Thai patients receiving combination
antiretroviral treatment. HIV Medicine, 8(1),
46-54.
2006
Boyd, M., Srasuebkul, P., Khongphattanayothin,
M., Ruxrungtham, K., Hassink, E., Duncombe,
C., Ubolyam, S., Burger, D., Reiss, P., Stek Jr,
M., et al (2006). Boosted versus unboosted
indinavir with zidovudine and lamivudine in
nucleoside pre-treated patients: a randomized,
open-label trial with 112 weeks of follow-up
(HIV-NAT 005). Antiviral Therapy, 11(2),
223-232.
Boyd, M., Carr, A., Ruxrungtham, K.,
Srasuebkul, P., Bien, D., Law, M.,
Wangsuphachart, S., Krisanachinda, A.,
Lerdlum, S., Lange, J., et al (2006). Changes in
body composition and mitochondrial nucleic acid
Boyd, M., Srasuebkul, P., Ruxrungtham, K.,
Mackenzie, P., Uchaipichat, V., Stek Jr, M.,
Lange, J., Phanuphak, P., Cooper, D.,
Udomuksorn, W., et al (2006). Relationship
between hyperbilirubinaemia and
UDP-glucuronosyltransferase 1A1 (UGT1A1)
polymorphism in adult HIV-infected Thai
patients treated with indinavir. Pharmocogenet
Genomics, 16(5), 321-329. <a
href="http://dx.doi.org/10.1097/01.fpc.00001974
65.14340.d4">[More Information]</a>
2005
Cardiello, P., Hassink, E., Ananworanich, J.,
Srasuebkul, P., Samor, T., Mahanontharit, A.,
Ruxrungtham, K., Hirschel, B., Lange, J.,
Phanuphak, P., et al (2005). A propspective,
randomised trial of structured treatment
interruption for patients with chronic HIV Type
1 infection. Clinical Infectious Diseases, 40(4),
594-560.
Srasuebkul, P. (2005). Parametric models to
predict immunological failure in Thai patients
receiving Antiretroviral therapy. Australasia
society for HIV medicine conference 2005,
Hobart: ASHM - Australasian Society for HIV
Medicine.
Cardiello, P., Srasuebkul, P., Hassink, E.,
Mahanontharit, A., Samor, T., Ruxrungtham, K.,
Lange, J., Cooper, D., Phanuphak, P. (2005). The
48-week efficacy of once-daily
saquinavir/ritonavir in patients with undetectable
viral load after 3 years of antiretroviral therapy.
HIV Medicine, 6(2), 122-128.
2004
Ungsedhapand, C., Srasuebkul, P., Cardiello, P.,
Ruxrungtham, K., Ratanasuwan, W., Kroon, E.,
Tongtalung, M., Juengprasert, N., Ubolyam, S.,
Siangphoe, U., et al (2004). Three-year durability
of dual-nucleoside therapy in a Thai population
with HIV infection. JAIDS-Journal of Acquired
Immune Deficiency Syndromes, 36(2), 693-701.
<a
href="http://dx.doi.org/10.1097/00126334-20040
6010-00006">[More Information]</a>
Publications for Preeyaporn Srasuebkul
2003
Ananworanich, J., Nuesch, R., Teeratakulpisarn,
S., Srasuebkul, P., Chuenyam, T., Siangphoe, U.,
Ungsedhaphand, C., Phanuphak, P.,
Ruxrungtham, K. (2003). In vivo cell-mediated
immunity in subjects with undetectable viral load
on protease inhibitor-based versus non-protease
inhibitor-based highly active antiretroviral
therapy. JAIDS-Journal of Acquired Immune
Deficiency Syndromes, 32(5), 570-572.
2002
Pothikamjorn, S., Ruxrungtham, K.,
Thampanitchawong, P., Fuangthong, R.,
Srasuebkul, P., sangahsapaviriyah, A.,
Suttithavil, W., Klaewsongkram, J., Parisuthikul,
V., Viravan, T., et al (2002). Impact of
particulate air pollutants on allergic diseases,
allergic skin reactivity and lung function. Asian
Pacific Journal of Allergy and Immunology,
20(2), 77-83.
Cardiello, P., van Heeswijk, R., Hassink, E.,
Srasuebkul, P., Mahanontharit, A., Samor, T.,
Worarien, W., Beijnen, J., Hoetelmans, R.,
Ruxrungtham, K., et al (2002). Simplifying
protease inhibitor therapy with Once-Daily
Dosing of Saquinavir Soft-Gelatin
Capsules/Ritonavir (1600/100mg): HIVNAT
001.3 Study. JAIDS-Journal of Acquired Immune
Deficiency Syndromes, 29(5), 464-470.
2001
Srasuebkul, P. (2001). The Long-term efficacy of
saquinavir-soft gelatin capsules plus either
Combivir (AZT/3TC) or ddl/d4T in HIV1+ Thai
patients pretreated with AZT/ddC: HIV-NAT
001.1 and 001.2. Royal College of Physicians of
Thailand Meeting 2001, Thailand: Royal College
of Physicians of Thailand.